2014
DOI: 10.1038/ncomms5240
|View full text |Cite
|
Sign up to set email alerts
|

Allele-specific genome editing and correction of disease-associated phenotypes in rats using the CRISPR–Cas platform

Abstract: The bacterial CRISPR/Cas system has proven to be an efficient gene-targeting tool in various organisms. Here we employ CRISPR/Cas for accurate and efficient genome editing in rats. The synthetic chimeric guide RNAs (gRNAs) discriminate a single-nucleotide polymorphism (SNP) difference in rat embryonic fibroblasts, allowing allele-specific genome editing of the dominant phenotype in (F344 × DA)F1 hybrid embryos. Interestingly, the targeted allele, initially assessed by the allele-specific gRNA, is repaired by a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

4
124
1
3

Year Published

2014
2014
2023
2023

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 165 publications
(132 citation statements)
references
References 48 publications
(92 reference statements)
4
124
1
3
Order By: Relevance
“…The pre-implantation embryo stage is generally not favoured for genome editing as it would most likely lead to a mosaic individual and possibly to more unforeseen and unforeseeable detrimental effects. Various studies in different animal models have demonstrated the feasibility of gene-editing in animals at the zygote stage (Yoshimi et al, 2014;Heo et al, 2015;Han et al, 2014, Kang et al, 2014. The potential of the technology to prevent the onset of a genetic disorder in mice was demonstrated by the studies of Wu et al (2013) and Long et al (2014), respectively for cataract and Duchenne muscular dystrophy.…”
Section: Gene Editing In Zygotes/pre-implantation Embryosmentioning
confidence: 99%
“…The pre-implantation embryo stage is generally not favoured for genome editing as it would most likely lead to a mosaic individual and possibly to more unforeseen and unforeseeable detrimental effects. Various studies in different animal models have demonstrated the feasibility of gene-editing in animals at the zygote stage (Yoshimi et al, 2014;Heo et al, 2015;Han et al, 2014, Kang et al, 2014. The potential of the technology to prevent the onset of a genetic disorder in mice was demonstrated by the studies of Wu et al (2013) and Long et al (2014), respectively for cataract and Duchenne muscular dystrophy.…”
Section: Gene Editing In Zygotes/pre-implantation Embryosmentioning
confidence: 99%
“…We have also generated a targeted KO rat for the coat color gene, tyrosinase ( Tyr ), by microinjecting target-specifi c gRNA and Cas9 mRNA into fertilized eggs (Yoshimi et al 2014 ). Crossing founders demonstrated that the CRISPR/Cas9-mediated mutations were faithfully transmitted to the next generation (Li et al 2013a , b ;Ma et al 2014b ).…”
Section: Knockout Rats With Crispr/cas9mentioning
confidence: 97%
“…Studies using gene-editing in animals such as rats 5 , cattle 6 , sheep 7 and pigs 8 , indicate that it is possible to delete or disable genes in an embryo -a simpler process than actually correcting DNA sequences -in only some of the cells.…”
Section: Editing Toolsmentioning
confidence: 99%